Regeneron reports 2-year data from PANORAMA study of Eylea in diabetic retinopathy Feb. 10, 2020 No Comments
New aflibercept 8 mg formulation to enter phase III trials for DME and wet AMD Feb. 10, 2020 No Comments
Adverum reports new interim data from phase I trial of gene therapy ADVM-022 in wet AMD Feb. 10, 2020 No Comments